{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:12:02Z","timestamp":1795176722527,"version":"4.10.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41556-026-01913-z","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:02:18Z","timestamp":1773396138000},"page":"771-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-530X","authenticated-orcid":false,"given":"Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-3834","authenticated-orcid":false,"given":"Anke","family":"Vandekeere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-6848","authenticated-orcid":false,"given":"Xiao-Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-0484","authenticated-orcid":false,"given":"Stephan","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-3627","authenticated-orcid":false,"given":"Juan","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6710-4838","authenticated-orcid":false,"given":"Tine","family":"Tricot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8327-559X","authenticated-orcid":false,"given":"Yiming","family":"Peng-Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-3281","authenticated-orcid":false,"given":"Margherita","family":"Demicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-1607","authenticated-orcid":false,"given":"Dorien","family":"Broekaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-7410","authenticated-orcid":false,"given":"Ines","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1155-7594","authenticated-orcid":false,"given":"Janine","family":"Theile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-3830","authenticated-orcid":false,"given":"Gitte","family":"Zels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Pabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Desmedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4237-9322","authenticated-orcid":false,"given":"Janine D.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7075-2051","authenticated-orcid":false,"given":"Patricia","family":"Altea-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-9296","authenticated-orcid":false,"given":"Sarah-Maria","family":"Fendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1158\/2159-8290.CD-24-0174","volume":"14","author":"S Krieg","year":"2024","unstructured":"Krieg, S., Fernandes, S. I., Kolliopoulos, C., Liu, M. & Fendt, S.-M. Metabolic signaling in cancer metastasis. Cancer Discov. 14, 934\u2013952 (2024).","journal-title":"Cancer Discov."},{"key":"1913_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","volume":"17","author":"M-Q Shi","year":"2024","unstructured":"Shi, M.-Q. et al. Advances in targeting histone deacetylase for treatment of solid tumors. J. Hematol. Oncol. 17, 37 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"1913_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1200\/JCO.2023.41.16_suppl.1054","volume":"41","author":"D Sommerhalder","year":"2023","unstructured":"Sommerhalder, D. et al. First-in-human phase 1 dose escalation study of the KAT6 inhibitor PF-07248144 in patients with advanced solid tumors. J. Clin. Oncol. 41, 1054\u20131054 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1538-7445.AM2024-5795","volume":"84","author":"KS Straley","year":"2024","unstructured":"Straley, K. S. et al. Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems. Cancer Res. 84, 5795\u20135795 (2024).","journal-title":"Cancer Res."},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1021\/acschembio.5b00841","volume":"11","author":"CE McCullough","year":"2016","unstructured":"McCullough, C. E. & Marmorstein, R. Molecular basis for histone acetyltransferase regulation by binding partners, associated domains, and autoacetylation. ACS Chem. Biol. 11, 632\u2013642 (2016).","journal-title":"ACS Chem. Biol."},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00018-020-03599-4","volume":"78","author":"S Bahl","year":"2021","unstructured":"Bahl, S. & Seto, E. Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance. Cell. Mol. Life Sci. 78, 427\u2013445 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"1913_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn2788","volume":"11","author":"Y Fukata","year":"2010","unstructured":"Fukata, Y. & Fukata, M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161\u2013175 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"1913_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01366-z","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma. Cell Commun. Signal. 22, 46 (2024).","journal-title":"Cell Commun. Signal."},{"key":"1913_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"1913_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add2282","volume":"16","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice. Sci. Signal 16, eadd2282 (2023).","journal-title":"Sci. Signal"},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.cmet.2023.09.012","volume":"35","author":"AR Terry","year":"2023","unstructured":"Terry, A. R. et al. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metab. 35, 2060\u20132076.e2069 (2023).","journal-title":"Cell Metab."},{"key":"1913_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18565-8","volume":"11","author":"J-W Hao","year":"2020","unstructured":"Hao, J.-W. et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat. Commun. 11, 4765 (2020).","journal-title":"Nat. Commun."},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"114224","DOI":"10.1016\/j.celrep.2024.114224","volume":"43","author":"G Tomi\u0107","year":"2024","unstructured":"Tomi\u0107, G. et al. Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis. Cell Rep. 43, 114224 (2024).","journal-title":"Cell Rep."},{"key":"1913_CR14","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1158\/0008-5472.CAN-17-1536","volume":"77","author":"C Sharma","year":"2017","unstructured":"Sharma, C. et al. Protein acyltransferase DHHC3 regulates breast tumor growth, oxidative stress, and senescence. Cancer Res. 77, 6880\u20136890 (2017).","journal-title":"Cancer Res."},{"key":"1913_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","volume":"4","author":"P Altea-Manzano","year":"2023","unstructured":"Altea-Manzano, P. et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03baB signaling. Nat. Cancer 4, 344\u2013364 (2023).","journal-title":"Nat. Cancer"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s13577-022-00707-3","volume":"35","author":"X Han","year":"2022","unstructured":"Han, X. & Chen, J. KAT2A affects tumor metabolic reprogramming in colon cancer progression through epigenetic activation of E2F1. Hum. Cell 35, 1140\u20131158 (2022).","journal-title":"Hum. Cell"},{"key":"1913_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41419-021-04077-w","volume":"12","author":"D Lu","year":"2021","unstructured":"Lu, D. et al. KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death Dis. 12, 787 (2021).","journal-title":"Cell Death Dis."},{"key":"1913_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51754","volume":"9","author":"AF Domingues","year":"2020","unstructured":"Domingues, A. F. et al. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells. eLife 9, e51754 (2020).","journal-title":"eLife"},{"key":"1913_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","volume":"568","author":"I Elia","year":"2019","unstructured":"Elia, I. et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature 568, 117\u2013121 (2019).","journal-title":"Nature"},{"key":"1913_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15267","volume":"8","author":"I Elia","year":"2017","unstructured":"Elia, I. et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat. Commun. 8, 15267 (2017).","journal-title":"Nat. Commun."},{"key":"1913_CR21","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"1913_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ijms22020603","volume":"22","author":"M Tolomeo","year":"2021","unstructured":"Tolomeo, M. & Cascio, A. The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int. J. Mol. Sci. 22, 603 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1913_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature 586, 434\u2013439 (2020).","journal-title":"Nature"},{"key":"1913_CR24","unstructured":"Vandekeere, A., Fendt, S.-M., Benitah, S.-A. & Martin-Perez, M. in Methods in Cell Biology, Ch. 12 211\u2013243 (Academic Press, 2025)."},{"key":"1913_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2016.06.009","volume":"166","author":"H Gao","year":"2016","unstructured":"Gao, H. et al. Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 Signaling. Cell 166, 47\u201362 (2016).","journal-title":"Cell"},{"key":"1913_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"1913_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00637-3","volume":"10","author":"T Geukens","year":"2024","unstructured":"Geukens, T. et al. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program. NPJ Breast Cancer 10, 31 (2024).","journal-title":"NPJ Breast Cancer"},{"key":"1913_CR28","doi-asserted-by":"publisher","first-page":"988872","DOI":"10.3389\/fonc.2022.988872","volume":"12","author":"S Parik","year":"2022","unstructured":"Parik, S. et al. GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide. Front. Oncol. 12, 988872 (2022).","journal-title":"Front. Oncol."},{"key":"1913_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro, G. B. et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat. Cancer 2, 414\u2013428 (2021).","journal-title":"Nat. Cancer"},{"key":"1913_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","volume":"16","author":"XH Zhang","year":"2009","unstructured":"Zhang, X. H. et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67\u201378 (2009).","journal-title":"Cancer Cell"},{"key":"1913_CR31","first-page":"128","volume":"4","author":"S Garcia-Recio","year":"2023","unstructured":"Garcia-Recio, S. et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat. Cancer 4, 128\u2013147 (2023).","journal-title":"Nat. Cancer"},{"key":"1913_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"},{"key":"1913_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-cancerbio-062822-122840","volume":"8","author":"A Vandekeere","year":"2024","unstructured":"Vandekeere, A., El Kharraz, S., Altea-Manzano, P. & Fendt, S.-M. Metabolic rewiring during metastasis: the interplay between the environment and the host. Annu. Rev. Cancer Biol. 8, 269\u2013290 (2024).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"1913_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41419-022-05067-2","volume":"13","author":"S Hou","year":"2022","unstructured":"Hou, S. et al. TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin \u03b16. Cell Death Dis. 13, 609 (2022).","journal-title":"Cell Death Dis."},{"key":"1913_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5417-7","volume":"19","author":"C Gao","year":"2019","unstructured":"Gao, C., Yao, H., Liu, H., Feng, Y. & Yang, Z. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer. BMC Cancer 19, 237 (2019).","journal-title":"BMC Cancer"},{"key":"1913_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41392-022-01177-7","volume":"7","author":"G Chen","year":"2022","unstructured":"Chen, G. et al. Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells. Signal Transduct. Target. Ther. 7, 350 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1913_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2023.01.011","volume":"255","author":"Y Shen","year":"2023","unstructured":"Shen, Y. et al. Construction of CAR-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer. Immunol. Lett. 255, 1\u20139 (2023).","journal-title":"Immunol. Lett."},{"key":"1913_CR38","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/1535-7163.MCT-15-0188","volume":"14","author":"A Visintin","year":"2015","unstructured":"Visintin, A. et al. Novel anti-TM4SF1 antibody-drug conjugates with activity against tumor cells and tumor vasculature. Mol. Cancer Ther. 14, 1868\u20131876 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"1913_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molcel.2016.04.003","volume":"62","author":"KB Runkle","year":"2016","unstructured":"Runkle, K. B. et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol. Cell 62, 385\u2013396 (2016).","journal-title":"Mol. Cell"},{"key":"1913_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bbrc.2017.09.044","volume":"493","author":"A Kharbanda","year":"2017","unstructured":"Kharbanda, A., Runkle, K., Wang, W. & Witze, E. S. Induced sensitivity to EGFR inhibitors is mediated by palmitoylated cysteine 1025 of EGFR and requires oncogenic Kras. Biochem. Biophys. Res. Commun. 493, 213\u2013219 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1913_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49105-3","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat. Commun. 15, 4642 (2024).","journal-title":"Nat. Commun."},{"key":"1913_CR42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s41375-018-0117-x","volume":"32","author":"B Wingelhofer","year":"2018","unstructured":"Wingelhofer, B. et al. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer. Leukemia 32, 1713\u20131726 (2018).","journal-title":"Leukemia"},{"key":"1913_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-025-00557-2","volume":"14","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma. Oncogenesis 14, 13 (2025).","journal-title":"Oncogenesis"},{"key":"1913_CR44","doi-asserted-by":"publisher","first-page":"15673","DOI":"10.1074\/jbc.M413203200","volume":"280","author":"B Barr\u00e9","year":"2005","unstructured":"Barr\u00e9, B., Vigneron, A. & Coqueret, O. The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter. J. Biol. Chem. 280, 15673\u201315681 (2005).","journal-title":"J. Biol. Chem."},{"key":"1913_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/BJ20120941","volume":"447","author":"IH Ng","year":"2012","unstructured":"Ng, I. H., Ng, D. C., Jans, D. A. & Bogoyevitch, M. A. Selective STAT3-\u03b1 or -\u03b2 expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes. Biochem. J. 447, 125\u2013136 (2012).","journal-title":"Biochem. J."},{"key":"1913_CR46","doi-asserted-by":"publisher","first-page":"14192","DOI":"10.1074\/jbc.M111.323899","volume":"287","author":"OA Timofeeva","year":"2012","unstructured":"Timofeeva, O. A. et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J. Biol. Chem. 287, 14192\u201314200 (2012).","journal-title":"J. Biol. Chem."},{"key":"1913_CR47","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.2174\/0929867329666220819093117","volume":"30","author":"J Song","year":"2023","unstructured":"Song, J., Wang, J., Tian, S. & Li, H. Discovery of STAT3 inhibitors: recent advances and future perspectives. Curr. Med. Chem. 30, 1824\u20131847 (2023).","journal-title":"Curr. Med. Chem."},{"key":"1913_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tips.2024.01.010","volume":"45","author":"J White","year":"2024","unstructured":"White, J. et al. Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy. Trends Pharmacol. Sci. 45, 243\u2013254 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"1913_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118730","volume":"336","author":"J Guo","year":"2025","unstructured":"Guo, J. et al. Perilla frutescens leaf extracts alleviate acute lung injury in mice by inhibiting KAT2A. J. Ethnopharmacol. 336, 118730 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"1913_CR50","first-page":"3955","volume":"16","author":"L Zhao","year":"2018","unstructured":"Zhao, L., Pang, A. & Li, Y. Function of GCN5 in the TGF-\u03b21-induced epithelial-to-mesenchymal transition in breast cancer. Oncol. Lett. 16, 3955\u20133963 (2018).","journal-title":"Oncol. Lett."},{"key":"1913_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1006491619920","volume":"62","author":"FC von Lintig","year":"2000","unstructured":"von Lintig, F. C. et al. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62, 51\u201362 (2000).","journal-title":"Breast Cancer Res. Treat."},{"key":"1913_CR52","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1194\/jlr.M050237","volume":"55","author":"AK Leamy","year":"2014","unstructured":"Leamy, A. K. et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 55, 1478\u20131488 (2014).","journal-title":"J. Lipid Res."},{"key":"1913_CR53","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1021\/bi200178z","volume":"50","author":"ER Geertsma","year":"2011","unstructured":"Geertsma, E. R. & Dutzler, R. A versatile and efficient high-throughput cloning tool for structural biology. Biochemistry 50, 3272\u20133278 (2011).","journal-title":"Biochemistry"},{"key":"1913_CR54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599, 673\u2013678 (2021).","journal-title":"Nature"},{"key":"1913_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"1913_CR56","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1913_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"1913_CR58","first-page":"50031","volume":"18","author":"GS Brigidi","year":"2013","unstructured":"Brigidi, G. S. & Bamji, S. X. Detection of protein palmitoylation in cultured hippocampal neurons by immunoprecipitation and acyl-biotin exchange (ABE). J. Vis. Exp. 18, 50031 (2013).","journal-title":"J. Vis. Exp."},{"key":"1913_CR59","doi-asserted-by":"publisher","first-page":"100514","DOI":"10.1016\/j.xpro.2021.100514","volume":"2","author":"H Holliday","year":"2021","unstructured":"Holliday, H., Khoury, A. & Swarbrick, A. Chromatin immunoprecipitation of transcription factors and histone modifications in Comma-D\u03b2 mammary epithelial cells. STAR Protoc. 2, 100514 (2021).","journal-title":"STAR Protoc."},{"key":"1913_CR60","doi-asserted-by":"publisher","first-page":"38886","DOI":"10.1074\/jbc.M111.286245","volume":"286","author":"M Snyder","year":"2011","unstructured":"Snyder, M., Huang, X. Y. & Zhang, J. J. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J. Biol. Chem. 286, 38886\u201338893 (2011).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01913-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:02:24Z","timestamp":1776355344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-01913-z","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.-M.F. has received funding from BlackBelt Therapeutics, Auron Therapeutics and Alesta Therapeutics, is on the advisory board of Alesta Therapeutics and has consulted for Fund+ and Droia Ventures. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}